Nabriva Therapeutics AG ADR buy klostergang
Start price
25.08.17
/
50%
?7.59
Target price
27.08.18
€15.64
Performance (%)
-67.54%
End price
27.08.18
€2.46
Summary
This prediction ended on 27.08.18 with a price of €2.46. The BUY prediction by klostergang for Nabriva Therapeutics AG ADR performed very badly with a performance of -67.54%. klostergang has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Nabriva Therapeutics AG ADR | - | - | - | - |
iShares Core DAX® | -1.114% | 3.430% | 25.966% | 25.039% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% | 48.139% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% | 11.979% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% | 46.982% |
Comments by klostergang for this prediction
In the thread Nabriva Therapeutics AG ADR diskutieren
klostergang stimmt der Outperform-Einschätzung der institutionellen Analysten zu
klostergang stimmt am 25.08.2017 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 17.34$ zu.
(Laufzeit überschritten)